Alloy Therapeutics and KSAC Forge Strategic Alliance to Propel Global Growth of Japanese Life Science Startups Alloy Therapeutics Co. Ltd. (“Alloy Japan”) has entered into a strategic Memorandum of Understanding (MOU) with the Kansai Startup Academia Coalition (KSAC), an initiative…
MEI Pharma Makes Historic Move with $100 Million Private Placement to Launch Litecoin-Based Treasury Strategy, Appoints Charlie Lee to Board In a bold and unprecedented move that bridges the worlds of biotechnology and cryptocurrency, MEI Pharma, Inc. (Nasdaq: MEIP) has…
Bristol Myers Squibb Reports Topline Results from Phase 3 INDEPENDENCE Trial of Reblozyl in Myelofibrosis-Associated Anemia Bristol Myers Squibb (NYSE: BMY), a global leader in hematology and oncology innovation, has announced the topline results from its Phase 3 INDEPENDENCE trial…
PCI Pharma Services Embarks on Next Growth Phase with Strategic Investment from Bain Capital, Kohlberg, and Mubadala PCI Pharma Services (PCI), a globally recognized contract development and manufacturing organization (CDMO) specializing in cutting-edge biopharmaceuticals, has announced a major strategic investment…
CEL-SCI Secures $5.7 Million in At-the-Market Equity Offering to Advance Cancer Immunotherapy Program CEL-SCI Corporation (NYSE American: CVM), a clinical-stage biotechnology company dedicated to developing cancer immunotherapy treatments, has successfully closed a best-efforts equity offering that generated approximately $5.7 million…
WHO Member States Convene First IGWG Meeting, Set Roadmap for Implementing Pandemic Agreement In a significant step toward bolstering global health security, World Health Organization (WHO) Member States gathered for the inaugural meeting of the Intergovernmental Working Group (IGWG) on…
Merck Bolsters Respiratory Portfolio With $10B Verona Acquisition Ahead of Keytruda Patent Cliff In the second-largest biopharma acquisition of 2025, Merck is acquiring Verona Pharma for $10 billion, a strategic move to strengthen its respiratory pipeline and prepare for the…
Merck to Acquire Verona Pharma in $10 Billion Deal, Adding Ohtuvayre® to Strengthen Respiratory Portfolio and Expand Long-Term Growth in COPD Market Merck & Co., known as MSD outside the U.S. and Canada, today announced a definitive agreement to acquire…
Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology (2020–2025): An In-Depth Analysis of Industry Trends, Financials, and Strategic Partnerships new industry report titled “Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020–2025.” This updated resource offers a detailed examination of…
WHO Applauds IMF’s Landmark $700 Million Support to Jordan for Pandemic Preparedness and Response The World Health Organization (WHO) has lauded a groundbreaking decision by the International Monetary Fund (IMF) Executive Board to approve the first-ever Resilience and Sustainability Facility…
ISS Backs Glass Lewis in Supporting SINOVAC’s Current Board, Rejects Former Slate Ahead of Special Meeting SINOVAC Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that Institutional Shareholder Services Inc. (ISS), one of the most…
CroíValve Awarded €12.5M in Horizon Europe EIC Accelerator Funding to Advance Novel Treatment for Tricuspid Regurgitation CroíValve, a Dublin-based medical device company committed to transforming the treatment of tricuspid regurgitation (TR), has secured a major funding boost through the European…